BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp lessened its stake in shares of Danaher Corporation (NYSE:DHR) by 28.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 245,867 shares of the conglomerate’s stock after selling 95,704 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp’s holdings in Danaher Corporation were worth $20,749,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the business. Tirschwell & Loewy Inc. grew its holdings in Danaher Corporation by 2.1% during the second quarter. Tirschwell & Loewy Inc. now owns 242,435 shares of the conglomerate’s stock valued at $20,459,000 after purchasing an additional 4,904 shares during the last quarter. Pinnacle Financial Partners Inc. grew its holdings in Danaher Corporation by 17.4% during the second quarter. Pinnacle Financial Partners Inc. now owns 18,620 shares of the conglomerate’s stock valued at $1,572,000 after purchasing an additional 2,756 shares during the last quarter. Pitcairn Co. grew its holdings in Danaher Corporation by 4.5% during the second quarter. Pitcairn Co. now owns 49,703 shares of the conglomerate’s stock valued at $4,194,000 after purchasing an additional 2,141 shares during the last quarter. Bourgeon Capital Management LLC grew its holdings in Danaher Corporation by 2.7% during the second quarter. Bourgeon Capital Management LLC now owns 66,765 shares of the conglomerate’s stock valued at $5,634,000 after purchasing an additional 1,750 shares during the last quarter. Finally, Sigma Planning Corp grew its holdings in Danaher Corporation by 23.5% during the second quarter. Sigma Planning Corp now owns 4,928 shares of the conglomerate’s stock valued at $416,000 after purchasing an additional 937 shares during the last quarter. Institutional investors own 75.68% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Has $20.75 Million Holdings in Danaher Corporation (DHR)” was originally published by Daily Political and is the sole property of of Daily Political. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this story can be viewed at https://www.dailypolitical.com/2017/09/21/british-columbia-investment-management-corp-has-20-75-million-holdings-in-danaher-corporation-dhr.html.

DHR has been the topic of several research analyst reports. Janney Montgomery Scott downgraded shares of Danaher Corporation from a “buy” rating to a “neutral” rating in a research note on Wednesday, June 7th. BidaskClub downgraded shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research note on Saturday, July 8th. Wells Fargo & Company restated a “market perform” rating on shares of Danaher Corporation in a research note on Saturday, July 22nd. J P Morgan Chase & Co restated an “overweight” rating and issued a $95.00 price objective on shares of Danaher Corporation in a research note on Friday, September 8th. Finally, Citigroup Inc. set a $96.00 price objective on shares of Danaher Corporation and gave the stock a “buy” rating in a research note on Friday, July 21st. One analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company. Danaher Corporation presently has an average rating of “Buy” and a consensus target price of $92.72.

In other Danaher Corporation news, insider William King sold 7,458 shares of the company’s stock in a transaction on Friday, July 21st. The stock was sold at an average price of $82.97, for a total value of $618,790.26. Following the transaction, the insider now directly owns 18,245 shares of the company’s stock, valued at approximately $1,513,787.65. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Linda P. Hefner sold 10,578 shares of the company’s stock in a transaction on Friday, July 21st. The shares were sold at an average price of $83.03, for a total value of $878,291.34. Following the completion of the transaction, the director now directly owns 42,151 shares in the company, valued at $3,499,797.53. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 71,496 shares of company stock worth $5,916,223. Insiders own 12.20% of the company’s stock.

Shares of Danaher Corporation (DHR) opened at 86.46 on Thursday. The firm’s 50-day moving average is $82.99 and its 200-day moving average is $84.20. The firm has a market cap of $60.06 billion, a P/E ratio of 27.60 and a beta of 1.03. Danaher Corporation has a 1-year low of $75.71 and a 1-year high of $88.62.

Danaher Corporation (NYSE:DHR) last issued its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, beating analysts’ consensus estimates of $0.97 by $0.02. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The firm had revenue of $4.51 billion for the quarter, compared to analyst estimates of $4.50 billion. During the same period in the prior year, the firm posted $0.90 EPS. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. On average, analysts anticipate that Danaher Corporation will post $3.95 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 29th will be issued a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a yield of 0.65%. The ex-dividend date of this dividend is Thursday, September 28th. Danaher Corporation’s dividend payout ratio is 17.83%.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.